Top Abstract Purchase Related
Home
>
Node
>
Subnode

Short heparin thrombin clotting time, increased fibrinogen and platelet aggregates count in coronary disease: a probable hypercoagulable state

Patrassi, G.M.; Toffanin, F.; Massa, G.; Schivazappa, L.; Girolami, A.

Folia Haematologica 106(3): 414-425

1979

ISSN/ISBN: 0323-4347
PMID: 89993
Document Number: 141712
Several indices of plasma and platelet coagulability (HTCT ) may also influence the test. No positive correlation between HTCT and AT III could be observed. The elevated levels of AT III in acute myocardial infarction did not confirm AT III consumption due to chronic intravascular coagulation in these patients. The Wu-Hoak test increased only in patients with acute coronary disease. HTCT is a valid test for diagnosis of hypercoagulability.

Document emailed within 1 workday
Secure & encrypted payments

Yang, D.-h.; Tan, N.; He, P.-c.; Liu, Y.; Wen, J.-y.; Chen, J.-y.; Zhou, Y.-l.; Huang, W.-h. 2012: Increased platelet-leukocyte aggregates in patients with acute coronary syndrome Zhonghua Xin Xue Guan Bing Za Zhi 40(6): 482-486
Li, J.; Liu, Z.; Zhang, S.; Shen, Z.; Fan, Z.; Zeng, Y.; Xie, H.; Wang, C.; Jin, X.; Fang, Q.; Zhu, W. 2015: Activated clotting time post therapeutic anticoagulation with unfractionated heparin in patients undergoing elective percutaneous coronary intervention Zhonghua Xin Xue Guan Bing Za Zhi 43(5): 408-412
Omoregie, R.; Osakue, S.I.; Ihemeje, V.; Omokaro, E.U.; Ogeferet, H.O. 2009: Correlation of CD4 count with platelet count, prothrombin time and activated partial thromboplastin time among HIV patients in Benin City, Nigeria West Indian Medical Journal 58(5): 437-440
Sonder, S.A.; Fenton, J.W. 1986: Thrombin specificity with tripeptide chromogenic substrates: comparison of human and bovine thrombins with and without fibrinogen clotting activities Clinical Chemistry 32(6): 934-937
Mäkinen, T.; Tötterman, T.H.; Gordin, A.; Weber, T.H. 1977: Migration inhibition factor and the blood clotting system: effects of defibrination, heparin and thrombin Clinical and Experimental Immunology 29(1): 181-186
Lindemann, S.; Klingel, B.; Fisch, A.; Meyer, J.; Darius, H. 1999: Increased platelet sensitivity toward platelet inhibitors during physical exercise in patients with coronary artery disease Thrombosis Research 93(2): 51-59
Winichagoon, P.; Fucharoen, S.; Wasi, P. 1981: Increased circulating platelet aggregates in thalassaemia Southeast Asian Journal of Tropical Medicine and Public Health 12(4): 556-560
Eldor, A.; Maclouf, J.; Lellouche, F.; Ben-Yashar, V.; Barenholz, Y.; Durst, R.; Hy-Am, E.; Goldfarb, A.; Rachmilewitz, E. 1993: A chronic hypercoagulable state and life-long platelet activation in beta thalassemia major Southeast Asian Journal of Tropical Medicine and Public Health 24(Suppl 1): 92-95
Arends, J.P.; Krediet, R.T.; Boeschoten, E.W.; van der Lelie, J.; Veenhof, C.H.; von dem Borne, A.E. 1981: Improvement of bleeding time, platelet aggregation and platelet count during CAPD treatment Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association 18: 280-285
Harff, G.A.; Caroline C.Vrijland, A.; Dijkstra, J.B.; Maria J.A. van den Bosch and Jacques P. A.M. Schönberger 2003: Impact of Allogenic Blood Transfusions on Temperature, Platelet Count and Differential Leukocyte Count of Patients after Coronary Artery Bypass Grafting Clinical Laboratory 49(3-4): 143-146
Kudriashov, B.A.; Liapina, L.A.; Ul'ianov, A.M. 1978: Importance of the fibrinogen-heparin complex in the fibrinolytic activity of the blood euglobulin fraction after the intravenous administration of thrombin or plasmin Voprosy Meditsinskoi Khimii 24(2): 255-260
Berglund, U.; Wallentin, L. 1991: Influence on platelet function by heparin in men with unstable coronary artery disease Thrombosis and Haemostasis 66(6): 648-651
Ruggiero, H.A.; Fustinoni, O.; Luzzi, R.; Rebecchi, L.H. 1977: Disorders of blood coagulation, platelet adhesiviness and platelet count in the intermediate coronary syndrome Archivos del Instituto de Cardiologia de Mexico 47(1): 37-51
Hemker, H.C.; Kop, J.; Willems, G.M. 1979: Kinetic aspects of the interaction of blood clotting enzymes. VIII. the relation between clotting time and clotting velocity Thrombosis and Haemostasis 41(2): 309-313
Kudriashov, B.A.; Baskova, I.P.; Orlova, A.S.; Shapiro, F.B. 1981: Effect of hirudin-thrombin and phenylmethylsulfonyl-thrombin on various blood clotting indices Biulleten' Eksperimental'noi Biologii i Meditsiny 91(3): 307-309
Akl, B.F.; Vargas, G.M.; Neal, J.; Robillard, J.; Kelly, P. 1980: Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass Journal of Thoracic and Cardiovascular Surgery 79(1): 97-102
Béguin, S.; Lindhout, T.; Hemker, H.C. 1989: The effect of trace amounts of tissue factor on thrombin generation in platelet rich plasma, its inhibition by heparin Thrombosis and Haemostasis 61(1): 25-29
Wilhelmsson, S.; Lins, L.E. 1976: Whole-blood thrombin time: a bedside method for determination of heparin activity Clinical Nephrology 6(6): 523-525
Kastendieck, E.; Barthels, M. 1974: The rapid determination of fibrin and fibrinogen split products with a bedside thrombin coagulase time test in obstetric coagulopathies Geburtshilfe und Frauenheilkunde 34(9): 758-762
Trowbridge, E.A.; Martin, J.F. 1987: The platelet volume distribution: a signature of the prethrombotic state in coronary heart disease? Thrombosis and Haemostasis 58(2): 714-717